1-Methylpiperidine-4-carbaldehyde → HCID 86623554, Verbindung

HRID 391049

Reaktionsgleichung

Reaktionsgleichung von HRID 391049
[Cl:1][C:2]1[N:3]=[C:4]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)[C:5]2[S:10][C:9]([CH2:11][NH:12][CH3:13])=[CH:8][C:6]=2[N:7]=1.[CH3:20][N:21]1[CH2:26][CH2:25][CH:24]([CH:27]=O)[CH2:23][CH2:22]1>>[Cl:1][C:2]1[N:3]=[C:4]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)[C:5]2[S:10][C:9]([CH2:11][N:12]([CH3:13])[CH2:27][CH:24]3[CH2:23][CH2:22][N:21]([CH3:20])[CH2:26][CH2:25]3)=[CH:8][C:6]=2[N:7]=1

Komponenten

3

Versuchsvorschrift

Reaction between (2-chloro-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-ylmethyl)-methyl-amine and 1-methylpiperidine-4-carbaldehyde using standard reductive amination conditions yielded (2-chloro-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-ylmethyl)-methyl-(1-methyl-piperidin-4-ylmethyl)-amine, which was reacted with 2-aminopyrimidine-5-boronic acid in General Procedure A. Acid/base work-up and trituration with ether yielded 335. 400 MHz 1H NMR CDCl3: 9.30 (s, 2H), 7.26 (s, 1H), 5.30 (br s, 2H, NH2), 4.04 (t, 4H, J4.5), 3.90 (t, 4H, J4.5), 3.80 (s, 2H), 2.87 (d, 2H, J11.5), 2.33 (d, 2H, J7.1), 2.30 (s, 3H), 2.28 (s, 3H), 1.93 (t, 2H, J11.7), 1.83 (d, 2H, J13.1), 1.57-1.51 (m, 1H), 1.32-1.22 (m, 2H). LC-MS (m+1)=469.35

Quellen und Nachweise

ORD-Eintrag
ord-3cbcf9981135497fb6a6e7b12863ae99
Quelldatensatz
uspto-grants-2013_02
Patentnummer
US08383620B2

Verknüpfte Notizen

Wird geladen…